JPWO2019199861A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019199861A5
JPWO2019199861A5 JP2021505184A JP2021505184A JPWO2019199861A5 JP WO2019199861 A5 JPWO2019199861 A5 JP WO2019199861A5 JP 2021505184 A JP2021505184 A JP 2021505184A JP 2021505184 A JP2021505184 A JP 2021505184A JP WO2019199861 A5 JPWO2019199861 A5 JP WO2019199861A5
Authority
JP
Japan
Prior art keywords
approximately
pharmaceutical composition
cannabidiol
formulated
hemp extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505184A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021521277A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/026631 external-priority patent/WO2019199861A2/en
Publication of JP2021521277A publication Critical patent/JP2021521277A/ja
Publication of JPWO2019199861A5 publication Critical patent/JPWO2019199861A5/ja
Priority to JP2024045083A priority Critical patent/JP2024083365A/ja
Pending legal-status Critical Current

Links

JP2021505184A 2018-04-09 2019-04-09 動物における疼痛の処置のためのアサ抽出物 Pending JP2021521277A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024045083A JP2024083365A (ja) 2018-04-09 2024-03-21 動物における疼痛の処置のためのアサ抽出物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862655170P 2018-04-09 2018-04-09
US62/655,170 2018-04-09
PCT/US2019/026631 WO2019199861A2 (en) 2018-04-09 2019-04-09 Hemp extract for treatment of pain in animals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024045083A Division JP2024083365A (ja) 2018-04-09 2024-03-21 動物における疼痛の処置のためのアサ抽出物

Publications (2)

Publication Number Publication Date
JP2021521277A JP2021521277A (ja) 2021-08-26
JPWO2019199861A5 true JPWO2019199861A5 (pt) 2022-04-21

Family

ID=68163314

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021505184A Pending JP2021521277A (ja) 2018-04-09 2019-04-09 動物における疼痛の処置のためのアサ抽出物
JP2024045083A Pending JP2024083365A (ja) 2018-04-09 2024-03-21 動物における疼痛の処置のためのアサ抽出物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024045083A Pending JP2024083365A (ja) 2018-04-09 2024-03-21 動物における疼痛の処置のためのアサ抽出物

Country Status (11)

Country Link
US (2) US20230110830A1 (pt)
EP (1) EP3773528B1 (pt)
JP (2) JP2021521277A (pt)
CN (1) CN112969452A (pt)
AU (1) AU2019251357B2 (pt)
BR (1) BR112020020850A2 (pt)
CA (1) CA3096842A1 (pt)
ES (1) ES2973731T3 (pt)
MX (1) MX2020010603A (pt)
SG (1) SG11202010006UA (pt)
WO (1) WO2019199861A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019299213A1 (en) * 2018-07-02 2021-02-11 Companion Sciences, Llc Cannabidiol combination compositions
US11484487B1 (en) * 2018-07-23 2022-11-01 Robell Research, Inc. Gingivitis gum serum
CN114727970A (zh) * 2019-07-02 2022-07-08 艾乐文特科学公司 用于治疗动物中的疼痛、癌症和癫痫的大麻提取物
CN111956664A (zh) * 2019-12-03 2020-11-20 云南汉盟制药有限公司 一种宠物用组合物及其应用
AU2020412501A1 (en) * 2019-12-24 2022-08-18 Cannadol Pharmaceuticals Ltd Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety
AU2021227227A1 (en) * 2020-02-25 2022-10-13 The Queen's Medical Center Cannabinoid compositions
AU2021268900A1 (en) * 2020-05-04 2023-01-05 Agronomed Management, Llc Topical anti-inflammatory cannabinoid compositions
AU2021215262B2 (en) * 2020-06-12 2023-12-14 Zelira Therapeutics Operations Pty Ltd Composition and method for treating chronic pain
US20220110888A1 (en) * 2020-10-09 2022-04-14 Charlotte's Web, Inc. Composition for the treatment of psoriasis
WO2023130161A1 (en) * 2022-01-10 2023-07-13 Dolce Cann Global Pty Ltd Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent
WO2023130160A1 (en) * 2022-01-10 2023-07-13 Dolce Cann Global Pty Ltd Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda).
WO2023173060A1 (en) * 2022-03-10 2023-09-14 Portland Technology Holdings Llc Compositions comprising hemp extract and related treatment methods
WO2024082014A1 (en) * 2022-10-21 2024-04-25 Dolce Cann Global Pty Ltd Compositions comprising cannabidiolic acid and fatty acids
KR102524364B1 (ko) * 2022-10-24 2023-04-24 전북대학교산학협력단 칸나비디올 및 타우린을 포함하는 치주염 예방 또는 치료용 조성물

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10051427C1 (de) 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
US8034843B2 (en) 2002-02-01 2011-10-11 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
EP1559423A1 (en) * 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
CN1840051B (zh) * 2006-01-23 2013-08-28 北京因科瑞斯生物制品研究所 一种麝香祛痛凝胶及其制备方法
US8481085B2 (en) 2006-06-15 2013-07-09 Gw Pharma Limited Pharmaceutical compositions comprising cannabigerol
GB2448535A (en) 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
GB2450493A (en) 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
DE602007011766D1 (de) 2007-10-02 2011-02-17 Vivacell Biotechnology Espana S L Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
NL2006621C2 (en) * 2011-04-18 2012-10-22 Fytagoras B V New medical use for acidic cannabinoids.
US8758826B2 (en) 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
JP2014534178A (ja) 2011-09-30 2014-12-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 癌の処置方法
US9254272B2 (en) 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
WO2013147965A1 (en) * 2012-03-28 2013-10-03 Freeman Keith Gerald Medical compositions, methods of making and using those compositions, and kits including those compositions
US20140256692A1 (en) * 2013-03-07 2014-09-11 Nicholas Adam Brockman Composition and Method for Alleviation of Pain and Inflammation
GB2515312A (en) 2013-06-19 2014-12-24 Gw Pharma Ltd The use of phytocannabinoids in the treatment of ovarian carcinoma
WO2015025312A1 (en) * 2013-08-21 2015-02-26 Cannabics Pharmaceuticals Inc Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof
AU2014347807A1 (en) * 2013-10-31 2016-05-26 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
WO2015069763A2 (en) 2013-11-05 2015-05-14 First Watersign Llc Sublingual cannabis dosage form and methods of making and using the same
GB2527590A (en) 2014-06-27 2015-12-30 Otsuka Pharma Co Ltd Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
US20160000843A1 (en) 2014-07-01 2016-01-07 MJAR Holdings, LLC High cannabidiol cannabis strains
US9394510B2 (en) 2014-08-25 2016-07-19 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of compounds
CA2965493C (en) * 2014-10-21 2021-12-07 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
WO2016087649A2 (en) 2014-12-04 2016-06-09 Servicio Andaluz De Salud Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues
MX2017007550A (es) * 2014-12-12 2018-05-04 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides.
MX2017009846A (es) 2015-01-31 2018-04-11 Constance Therapeutics Inc Metodos para la preparacion de extractos y composiciones de aceite de cannabis.
AU2016215094B2 (en) * 2015-02-05 2019-09-26 Colorado Can Llc Purified CBD and CBDA, and methods, compositions and products employing CBD or CBDA
ES2860452T3 (es) 2015-02-16 2021-10-05 Apirx Pharmaceutical Usa Llc Composiciones cosméticas y tópicas que comprenden cannabigerol y cannabidiol
US20170266153A1 (en) 2015-02-27 2017-09-21 Ebbu, LLC Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
WO2016141056A1 (en) * 2015-03-02 2016-09-09 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
AU2016261707A1 (en) 2015-05-13 2017-12-07 One World Cannabis Ltd Use of cannabis to treat fibromyalgia, methods and compositions thereof
EP3302033A4 (en) 2015-05-28 2018-10-31 Tweed Inc. Cannabis plants having modified expression of thca synthase
KR102460440B1 (ko) * 2015-07-22 2022-10-28 피토파마 인터내셔널 리미티드 꿀벌―섭취가능한 조성물, 이를 이용한 꿀 생산 방법 및 이에 의해 생산된 꿀
US10064950B2 (en) 2015-07-24 2018-09-04 Shabana Naheed Medication dispensing system
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2542797A (en) 2015-09-29 2017-04-05 Gw Pharma Ltd Use of cannabinoids in the treatment of inflammatory skin diseases
CA3006182A1 (en) * 2015-11-24 2017-06-01 Constance Therapeutics, Inc. Cannabis oil compositions and methods for preparation thereof
US9956173B1 (en) 2016-02-08 2018-05-01 Jeff Nordahl Packaged frozen cubes of cannabis juice purée that are non-psychoactive
GB2549277B (en) 2016-04-11 2021-02-17 Gw Res Ltd Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder
US10265362B2 (en) 2016-04-12 2019-04-23 Scott Schaneville Ingestible films having substances from hemp or cannabis
MX2018012448A (es) 2016-04-12 2019-07-08 Habi Pharma Pty Ltd Preparacion liposomal y metodos de tratamiento.
LT6486B (lt) * 2016-04-13 2018-01-10 UAB "SatiMed" Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
CN106074465A (zh) * 2016-06-14 2016-11-09 云南瑞酚生物科技有限公司 大麻酚类化合物在制备治疗痛风性关节炎药物中的应用
IL246790A0 (en) 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
KR20220132674A (ko) * 2016-08-03 2022-09-30 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
BR112019003815A2 (pt) 2016-08-29 2019-05-21 Canopy Growth Corporation composições solúveis em água compreendendo canabinoides purificados
EP4364593A2 (en) 2016-09-14 2024-05-08 Altria Client Services LLC Smoking device
IL248149B (en) * 2016-09-29 2020-03-31 Garti Nissim Formulations of dilutable cannabinoids and processes for their preparation
EP3571307A1 (en) * 2017-01-14 2019-11-27 Herbolea Biotech S.R.L. Enzyme-assisted lipid-based extraction and stabilization of phyto-cannabinoids and terpens and products obtained thereof
JP2020513805A (ja) 2017-03-18 2020-05-21 マクガラー,スティーブン,エム. カンナビジオール酸を含むペットフード
US20200093785A1 (en) 2017-03-24 2020-03-26 Deidra Stauff Skin care compositions and methods
EP3599831A4 (en) 2017-04-05 2020-12-09 University Of Mississippi ISOLATION OF PURE CANNABINOIDS FROM CANNABIS
AU2018266262B2 (en) 2017-05-08 2022-10-06 Inmed Pharmaceuticals Inc. Ocular drug delivery formulation
CA3064563A1 (en) 2017-05-22 2018-11-29 Gbs Global Biopharma, Inc. Myrcene-containing complex mixtures targeting trpv1
WO2019003163A2 (en) 2017-06-28 2019-01-03 Buzzelet Development And Technologies Ltd. CANNABINOID PRODUCT ENRICHED IN TERPENE GOOD FOR WOMEN'S HEALTH
DE18837223T1 (de) 2017-07-26 2020-03-26 Tgx Soft Chew, Llc Stärkefreier weicher kausnack für veterinärmedizinische anwendungen
US10597348B1 (en) 2017-08-21 2020-03-24 Jeff Nordahl Infusing raw cannabinoids into food oil
US10272051B2 (en) 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
US11484510B2 (en) 2017-08-28 2022-11-01 Apirx Pharmaceutical Usa, Llc Method to treat vitiligo
US20190060250A1 (en) 2017-08-28 2019-02-28 Axim Biotechnologies, Inc. Method to treat psoriasis
EP3449992A1 (en) 2017-09-04 2019-03-06 Bionorica Ethics GmbH Recovery of acidic cannabinoids from plant material
IL272709B1 (en) 2017-09-08 2024-05-01 Scicann Therapeutics Inc The compounds containing cannabinoid and spilantol
US10654823B2 (en) 2017-09-09 2020-05-19 Scientific Holdings, Llc Transparent glassy cannabinoid compositions
WO2019070876A2 (en) 2017-10-03 2019-04-11 The Regents Of The University Of Colorado METHOD FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES
WO2019071302A1 (en) 2017-10-09 2019-04-18 The University Of Sydney METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES
WO2019104442A1 (en) 2017-11-30 2019-06-06 Canopy Growth Corporation Liquid dosage forms, methods of making and use
US20200405685A1 (en) 2017-12-08 2020-12-31 Biotech Institute, Llc High cannabigerol cannabis plants, methods of producing and methods of using them
AU2019221321A1 (en) 2018-02-15 2020-10-01 Syqe Medical Ltd. Method and inhaler for providing two or more substances by inhalation
WO2019159176A1 (en) 2018-02-18 2019-08-22 Scicann Therapeutics Inc. Compositions and methods for treatment of neurodegenerative diseases
US20190297821A1 (en) 2018-03-28 2019-10-03 Jack Hempicine Llc Cross-hybridization of distinct homozygous cannabis plants to produce consistent early flowering seeds
WO2019195752A1 (en) 2018-04-05 2019-10-10 Canopy Holdings, LLC Hemp powder
WO2019210401A1 (en) 2018-05-01 2019-11-07 Willinsky Michael Novel anti-inflammatory, analgesic, anti-depressant cannabinoid and methods related to manufacture of same
WO2019227167A1 (en) 2018-06-01 2019-12-05 The University Of Sydney Compositions and treatments
CA3048539A1 (en) 2018-07-03 2020-01-03 Virgil Macaluso Methods of heating cannabis plant material
US20200288659A1 (en) 2018-07-12 2020-09-17 Jack Hempicine Llc Production of cannabis plants and seeds using a targeted allele
US20200015440A1 (en) 2018-07-12 2020-01-16 Jack Hempicine Llc Production of cannabis plants and seeds using a targeted allele
US20200015441A1 (en) 2018-07-12 2020-01-16 Jack Hempicine Llc Production of cannabis plants and seeds using a targeted allele
IL279824B2 (en) 2018-07-19 2023-10-01 Al& Am Pharmachem Ltd A process for the separation and purification of tetrahydrocannabinolic acid and cannabidiol acid from plant extracts
US20200038305A1 (en) 2018-08-02 2020-02-06 Divios LLC Sunscreen or Sunblock Composition
EP3843763A4 (en) 2018-08-27 2022-06-15 Emerald Health Therapeutics Canada Inc. IMPROVED CANNABINOID BIOAVAILABILITY
US20210205236A1 (en) 2018-08-27 2021-07-08 Emerald Health Therapeutics Canada Inc. Therapeutic combinations of boswellia extract and cannabinoids
MX2021002719A (es) 2018-09-05 2021-09-23 Nemus Bioscience Inc Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.
WO2020081108A1 (en) 2018-10-18 2020-04-23 Taba Ip, Llc Purification of cannabinoids from crude cannabis oil
WO2020084427A1 (en) 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Temperature control for active compound extraction
WO2020123383A1 (en) 2018-12-10 2020-06-18 Natural Extraction Systems, LLC Compositions with novel cannabinoid and terpene profiles
US20220040144A1 (en) 2018-12-12 2022-02-10 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl)
WO2020165902A1 (en) 2019-02-15 2020-08-20 Plantbiosis Ltd. Method for synthesis of cannabis products
NL2022616B1 (en) 2019-02-21 2020-09-18 Patrick Alexander Unger Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia

Similar Documents

Publication Publication Date Title
EP3773528B1 (en) Hemp extract for treatment of pain in animals
US20120225053A1 (en) Compositions and methods for the prevention and treatment of conditions associated with inflamation
US20110086119A1 (en) Preparation for the relief of disease
JPWO2019199861A5 (pt)
CN1927160A (zh) 漱口液及制备方法
AU2001295769A1 (en) A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
WO2004028549A1 (fr) Capsules de coixenolide destinees au traitement d'une maladie prostatique
JP2007297370A (ja) 血糖値上昇抑制剤
WO2007116980A1 (ja) 血糖値上昇抑制剤
WO2021150595A1 (en) Novel formulations comprising cannabis
JP2001048802A (ja) 糖尿病に有効な健康補助食品およびその使用方法、並びに糖尿病に有効な食品配合剤
JP7162357B2 (ja) 桂皮酸誘導体の吸収促進剤
US20110118243A1 (en) Anti-inflammatory drug delivery system
US20230056488A1 (en) Composition, article and method for affecting a mammal
WO2008075649A1 (ja) 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法
CN106163510A (zh) 褪黑素分泌调节剂、褪黑素分泌调节方法
US20230404942A1 (en) Life Extension and Quality of Life Improvement for Humans
JP4415063B1 (ja) 脂肪低減剤
JP4469406B1 (ja) 血中コレステロール低下剤
EP3919050A1 (en) Nutraceutic composition containing limonene and a dry extract of cocoa fibre for the treatment of obesity
KR20210023872A (ko) Rls 치료를 위한 님
CA3196828A1 (fr) Nouvelle composition therapeutique a base d'huiles essentielles a faibles doses
CN116940343A (zh) 关节炎和银屑病的补充剂
CN105832970A (zh) 蜂胶薄荷酊及其制备方法
JP2008174536A (ja) 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法